Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers achieves targets for 2024 fiscal year with strong fourth quarter
Press release

Siemens Healthineers achieves targets for 2024 fiscal year with strong fourth quarter

Siemens Healthineers AG today announces its results for the fourth quarter of fiscal year 2024 ended September 30, 2024, and the full fiscal year 2024.
Published on November 6, 2024

Fiscal Year 2024 – Targets achieved for revenue growth and earnings per share 

  • Very good equipment book-to-bill ratio of 1.11; continued expansion of order backlog 
  • Comparable revenue growth of 4.7% despite current difficult market conditions in China; excluding the rapid COVID-19 antigen-test business, which ended in the prior year, comparable revenue growth of 5.2% 
  • Adjusted EBIT margin of 15.7%, 0.7 percentage points above prior year; adjusted EBIT rose to €3.5 billion 
  • Adjusted basic earnings per share of €2.23 
  • Free cash flow of around €2.1 billion clearly above prior year 
  • Proposed dividend of €0.95 per share, unchanged from prior year

Q4 Fiscal Year 2024 – Marked revenue growth at Imaging, Varian and Advanced Therapies 

  • Very good equipment book-to-bill ratio of 1.12 
  • Comparable revenue growth of 5.6%; excluding the rapid COVID-19 antigen-test business, which ended in the prior-year quarter, comparable revenue growth of 6.5% 
  • Imaging comparable revenue growth of 7.7%, very good adjusted EBIT margin of 24.2% 
  • Diagnostics comparable revenue growth of 0.6% without rapid COVID-19 antigen tests; including the rapid antigen-test business, which has ended, comparable revenue declined by 3.8%; adjusted EBIT margin of 4.7% impacted by effects relating to prior periods 
  • Varian comparable revenue rose 10.5% from an outstanding prior-year quarter; adjusted EBIT margin of 17.1% 
  • Advanced Therapies comparable revenue growth of 6.8%; very good adjusted EBIT margin of 20.0% 
  • Overall adjusted EBIT margin of 17.7%, above prior-year quarter 
  • Free cash flow of €1.2 billion more than doubled from prior-year quarter 
  • Adjusted basic earnings per share of €0.67 

Outlook for Fiscal Year 2025 

For fiscal year 2025, we expect comparable revenue growth of between 5% to 6% compared with fiscal year 2024. We expect adjusted basic earnings per share to be between €2.35 and €2.50. 

Bernd Montag, CEO of Siemens Healthineers AG: 

»We achieved our targets for the fiscal year with a very good fourth quarter despite the current market weakness in China. This underlines the fundamental strength of our company and the contribution of the entire Healthineers team. We will carry this momentum into the 2025 financial year.«

Download Quarterly Statement(pdf, 291.35 KB)

Siemens Healthineers 2025

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. Sustainably. The company is a global provider of healthcare equipment, solutions and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. As a leading medical technology company, Siemens Healthineers is committed to improving access to healthcare for underserved communities worldwide and is striving to overcome the most threatening diseases. The company is principally active in the areas of imaging, diagnostics, cancer care and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2024, which ended on September 30, 2024, Siemens Healthineers had approximately 72,000 employees worldwide and generated revenue of around €22.4 billion. Further information is available at www.siemens-healthineers.com.